100% Quality Guarantee
PhD-Level Technical Support
Key Features

FITC Anti-Human CD28 Antibody [CD28.2] (AGEL2020)

SKU AGEL2020
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FC
Reactivity Human
Host Species Mouse
Isotype IgG2a,k
Clone CD28.2
Conjugation FITC
$42 - $218

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

FITC Anti-Human CD28 Antibody [CD28.2]

The Human CD28 Monoclonal Antibody FITC Conjugated (CD28-2) (AGel2020) is a vital tool for researchers studying CD28, a co-stimulatory molecule essential for T cell activation and immune response regulation. This antibody, engineered for high specificity and sensitivity, is ideal for flow cytometry applications, allowing for precise detection and analysis of CD28 expression on immune cells.CD28 plays a crucial role in mediating T cell activation and promoting immune responses, making it a key target for understanding and manipulating immune function in various diseases, including cancer, autoimmune disorders, and infectious diseases. The FITC conjugation of this monoclonal antibody enhances its performance for flow cytometry, enabling researchers to investigate CD28 expression levels on different T cell subsets and evaluate their functional implications.

With its reliable performance and validated application in flow cytometry, the Human CD28 Monoclonal Antibody FITC Conjugated (CD28-2) (AGel2020) is a valuable tool for advancing research in immunology, cancer biology, and autoimmune diseases. By facilitating the precise detection and analysis of CD28 expression, this antibody contributes to a deeper understanding of T cell activation mechanisms and immune response regulation, ultimately paving the way for the development of novel therapeutic strategies targeting CD28-related pathways.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose